Pharmafile Logo
Pharmafocus logo
Advanced Search

chronic heart failure

Showing 4 posts of 4 posts found.

teva_copy

Teva returns rights to heart cell therapy to Mesoblast

June 16, 2016
Research and Development, Sales and Marketing Mesoblast, Teva, chronic heart failure, phase III

Israeli drugmaker Teva (NYSE: TEVA) has returned full rights to a drug for heart condition in late stage trials to …

News
Novartis image

Novartis earns provisional NICE yes for Entresto

December 11, 2015
Sales and Marketing Entresto, NICE, Novartis, chronic heart failure, heart failure

NICE has indicated it is likely to recommend Entresto, a novel drug manufactured by Novartis, as a treatment option for …

News

Inspra performs strongly in heart failure patients

May 28, 2010
Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure

Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …

News

NICE to revamp chronic heart failure guidance

January 18, 2010
NHS, NICE, chronic heart failure

NICE is moving to update its clinical guidance on the management of chronic heart failure in adults. Draft recommendations are …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024